42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-06-106150
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => c1c786e5-4b61-48d5-8435-71d9dd96d2af
[Document ID] => 106150
[Document naam] => Raturi et al Covigenix Vaccine Preprint FINAL for circulation toBoard.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3339294-1026502-wjz/document/VWS-WOO-06-106150
[Opgeschort] =>
[Definitief ID] => VWS-WOO-06-106150
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3339294-1026502-wjz
[DocumentPublicationDate] => 14 juli 2020
[DocumentStatusCheckedDate] => 2026-04-29 04:18:56.238406
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 03:14:01
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 03:14:01
)
Document: VWS-WOO-06-106150
Klik om te vergroten
Document correcties
Geregistreerde datum: 20200714
Geregistreerde documentnaam: Raturi et al Covigenix Vaccine Preprint FINAL for circulation toBoard.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie | 9.256 documenten waarvan 4.168 openbaar gemaakt Inventarislijst | 2026-03-11 04:01:34 |
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 04:01:34 |
| Request_Omvang publicatie_paginas | 9.256 | 2026-03-11 04:01:34 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3339294-1026502-wjz/file/download/inventory | 2026-03-11 04:01:34 |
| About_Gelakte gegevens | 10.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 16:16:30 |
| document_SectionDownloadButton | 1 | 2025-09-01 16:16:30 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 16:16:30 |
| About_Type bronbestand | PDF, 26 pagina's | 2025-06-22 23:37:08 |
| About_Type bronbestand_paginas | 26 | 2025-06-22 23:37:08 |
| About_Download als | PDF (11.82 MB) | 2025-06-22 23:37:08 |
| About_Documentnummer | 106150 | 2025-06-22 23:37:08 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:37:08 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:37:08 |
| About_Gelakte gegevens_linkname_1 | 10.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:37:08 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:37:08 |
| document_SectionRelated | 1 | 2025-06-22 23:37:08 |
| document_SectionRequest | 1 | 2025-06-22 23:37:08 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Scenario's en maatregelen over de periode juli 2020 | 2025-06-22 23:37:08 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3339294-1026502-wjz | 2025-06-22 23:37:08 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Scenario's en maatregelen over de periode juli 2020 | 2025-06-22 23:37:08 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 25 maart 2022 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Scenario's en maatregelen over de periode juli 2020. | 2025-06-22 23:37:08 |
| Request_Periode | Juli 2020 | 2025-06-22 23:37:08 |
| Request_Type besluit | Wob-besluit | 2025-06-22 23:37:08 |
| Request_Datum besluit | 25 maart 2022 | 2025-06-22 23:37:08 |
| document_SectionHistory | 1 | 2025-06-22 23:37:08 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:37:08 |
| document_documentType | 2025-06-22 23:37:08 | |
| document_documentPublicationDate | 2020-07-14 | 2025-06-22 23:37:08 |
| document_documentNumber | VWS-WOO-06-106150 | 2025-06-22 23:37:08 |
| document_SectionHTMLDataDivs | 4 | 2025-06-22 23:37:08 |
| document_SectionAbout | 1 | 2025-06-22 23:37:08 |
| About_Datum document | 14 juli 2020 | 2025-06-22 23:37:08 |
| About_Gelakte gegevens | 10.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:37:08 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Raturi et al Covigenix Vaccine Preprint FINAL for circulation toBoard.pdf (documentnummer 1efad866-c5df-60d4-86e5-e9f5609852ee) | 2025-06-22 23:37:08 |
| Request_Omvang openbaarmaking | 9.256 documenten, 14.798 pagina's Inventarislijst | 2025-06-22 23:37:08 |
| Request_Omvang openbaarmaking_documenten | 9.256 | 2025-06-22 23:37:08 |
| Request_Omvang openbaarmaking_paginas | 14.798 | 2025-06-22 23:37:08 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3339294-1026502-wjz/file/download/inventory | 2025-06-22 23:37:08 |
| document_documentName | Raturi et al Covigenix Vaccine Preprint FINAL for circulation toBoard.pdf | 2025-06-22 23:37:08 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:37:08 |
| History Actie_2 | Bronbestand vervangen (pdf, 11.82 MB) | 2025-06-21 02:29:14 |
| History Datum_2 | 28 november 2024 15:18 | 2025-06-21 02:29:14 |
| History Actie_1 | Bronbestand vervangen (pdf, 11.82 MB) | 2025-06-21 02:29:14 |
| History Datum_1 | 28 november 2024 15:56 | 2025-06-21 02:29:14 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-06-106150.pdf | 2025-04-19 11:59:21 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3339294-1026502-wjz/file/download/document/1efad866-c5df-60d4-86e5-e9f5609852ee | 2025-04-19 11:59:21 |
| DocumentDownload_linkname | Download (pdf, 11.82 MB) | 2025-04-19 11:59:21 |
Archiefversies (9 rijen)
Archiefrij 1 — 2025-11-21 15:11:39
fromFile: VWS-WOO-3339294-1026502-wjz-1f0af2d1-008a-6c08-acb8-6738f30f9e3f.zip
fromFilePath: archieven_files\VWS-WOO-3339294-1026502-wjz-1f0af2d1-008a-6c08-acb8-6738f30f9e3f.zip
documentName: VWS-WOO-06-106150.pdf
documentType: pdf
documentCompressedSize: 9035473
documentSize: 12397432
documentCompressRatio: 72.8818113299593
documentDateModified: 2025-10-22 09:56:40
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:11:39
lastSeen: 2025-11-21 15:11:39
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2 DNA vaccine candidates
formulated with the Fusogenix proteo lipid vehicle delivery system
2
2
2
Ping Wee1 Prakash Bhanduri1 Manoj Parmar1 Douglas Brown2 Maryam
2
2
2
Grin1
Hector
Jennifer
Jaiial
Ablack1
Katia Carmine
Hejadi3 Liliya
Vega1
Gyo...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 48ee4cf42cb50ae8e2b373208a4ea7b992ed062d710b3d772a8eb34839304585
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 36d42b41-da4d-4095-9d9a-84ad41481446
textDigestSHA256: 00f537c4795ec09f204555f8bdbdc6b969db02f94de5dc541b416390e97fa0a8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 2 — 2025-11-21 15:07:44
fromFile: VWS-WOO-3339294-1026502-wjz-1f04b549-aed7-67a0-b99a-ed836029ca70.zip
fromFilePath: archieven_files\VWS-WOO-3339294-1026502-wjz-1f04b549-aed7-67a0-b99a-ed836029ca70.zip
documentName: VWS-WOO-06-106150.pdf
documentType: pdf
documentCompressedSize: 9035473
documentSize: 12397432
documentCompressRatio: 72.8818113299593
documentDateModified: 2025-10-22 09:56:40
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:07:44
lastSeen: 2025-11-21 15:07:44
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2 DNA vaccine candidates
formulated with the Fusogenix proteo lipid vehicle delivery system
2
2
2
Ping Wee1 Prakash Bhanduri1 Manoj Parmar1 Douglas Brown2 Maryam
2
2
2
Grin1
Hector
Jennifer
Jaiial
Ablack1
Katia Carmine
Hejadi3 Liliya
Vega1
Gyo...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 48ee4cf42cb50ae8e2b373208a4ea7b992ed062d710b3d772a8eb34839304585
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: ebed2fa6-0401-4b49-a6fc-255b34215f42
textDigestSHA256: 00f537c4795ec09f204555f8bdbdc6b969db02f94de5dc541b416390e97fa0a8
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 3 — 2025-09-08 18:22:53
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-06-106150.pdf
documentName: VWS-WOO-06-106150.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 12397432
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:22:53
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:22:53
lastSeen: 2025-09-08 18:22:53
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 48ee4cf42cb50ae8e2b373208a4ea7b992ed062d710b3d772a8eb34839304585
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_6290_98836507a75a8c122e9cfeaf97bb9647
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 4 — 2025-09-04 16:57:01
fromFile: VWS-WOO-3339294-1026502-wjz-1f026c98-e1ed-601e-831c-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3339294-1026502-wjz-1f026c98-e1ed-601e-831c-65673e0af118.zip
documentName: VWS-WOO-06-106150.pdf
documentType: pdf
documentCompressedSize: 9035473
documentSize: 12397432
documentCompressRatio: 72.8818113299593
documentDateModified: 2025-05-01 21:01:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:57:01
lastSeen: 2025-09-04 16:57:01
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 48ee4cf42cb50ae8e2b373208a4ea7b992ed062d710b3d772a8eb34839304585
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3339294-1026502-wjz-1f026c98-e1ed-601e-831c-65673e0af118.zip_961
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 5 — 2025-09-04 16:37:07
fromFile: VWS-WOO-3339294-1026502-wjz-1f04b549-aed7-67a0-b99a-ed836029ca70.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3339294-1026502-wjz-1f04b549-aed7-67a0-b99a-ed836029ca70.1.zip
documentName: VWS-WOO-06-106150.pdf
documentType: pdf
documentCompressedSize: 9035473
documentSize: 12397432
documentCompressRatio: 72.8818113299593
documentDateModified: 2025-06-17 08:26:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:37:07
lastSeen: 2025-11-21 13:47:41
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 48ee4cf42cb50ae8e2b373208a4ea7b992ed062d710b3d772a8eb34839304585
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3339294-1026502-wjz-1f04b549-aed7-67a0-b99a-ed836029ca70.zip_424
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 6 — 2025-03-18 09:30:24
fromFile: 2024.075-VWS-WOO-3339294-1026502-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3339294-1026502-wjz.zip
documentName: VWS-WOO-06-106150-Raturi_et_al_Covigenix_Vaccine_Preprint_FINAL_for_circulation_toBoard.pdf
documentType: pdf
documentCompressedSize: 9019023
documentSize: 12397432
documentCompressRatio: 72.74912256022054
documentDateModified: 2024-12-09 14:11:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:24
lastSeen: 2025-03-18 09:30:24
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 308686
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 7 — 2025-02-27 09:25:02
fromFile: Testverzoek-VWS-WOO-3339294-1026502-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Testverzoek-VWS-WOO-3339294-1026502-wjz.zip
documentName: VWS-WOO-06-106150-Raturi_et_al_Covigenix_Vaccine_Preprint_FINAL_for_circulation_toBoard.pdf
documentType: pdf
documentCompressedSize: 9019023
documentSize: 12397432
documentCompressRatio: 72.74912256022054
documentDateModified: 2024-12-09 14:11:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:02
lastSeen: 2025-02-27 09:25:02
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 218540
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 8 — 2025-02-18 12:36:08
fromFile: Besluit__dossier_nr_-c955cc656bc567754039b4f2e2c1af7494701a14ca91acba8aa0b0acd3677d58.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-c955cc656bc567754039b4f2e2c1af7494701a14ca91acba8aa0b0acd3677d58.zip
documentName: VWS-WOO-06-106150-Raturi_et_al_Covigenix_Vaccine_Preprint_FINAL_for_circulation_toBoard.pdf
documentType: pdf
documentCompressedSize: 9019023
documentSize: 12397432
documentCompressRatio: 72.74912256022054
documentDateModified: 2024-12-05 10:52:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:36:08
lastSeen: 2025-02-18 12:36:08
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 182654
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
Archiefrij 9 — 2025-02-18 12:18:12
fromFile: Besluit__dossier_nr_-a0fbe898fe8adeb44ee770da303d75abf81f9947dfcf417b582d9462217e0489.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-a0fbe898fe8adeb44ee770da303d75abf81f9947dfcf417b582d9462217e0489.zip
documentName: VWS-WOO-06-106150-Raturi_et_al_Covigenix_Vaccine_Preprint_FINAL_for_circulation_toBoard.pdf
documentType: pdf
documentCompressedSize: 9019023
documentSize: 12397432
documentCompressRatio: 72.74912256022054
documentDateModified: 2024-12-09 14:11:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:12
lastSeen: 2025-02-18 12:18:12
text: 106150
Rapid prototyping and iinmunogenicity ofSARS CoV 2DNA vaccine candidates
formulated with theFusogenix proteo lipidvehicle delivery system
Amn Raturi12Ping Wee12Prakash Bhanduri12Manoj Parmar12Douglas Brown2 Maryam
Hejadi3 Liliya Grin12Hector Vega12Jennifer Gyoba12 Jaiial Ablack12Katia Carmine...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 99720
textDigestSHA256: b3821f499ab14517318635c63124a74e276da333dc88cd42868c37bc476bf109
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-06-106150
(dit is ook een speeltuin)